Seems to be coming down after the initial spike because of short trading.
Guys ATSI got FDA approved before today market open to test aortic device in younger patients. The volume about to cross average volume. More details:
UPDATE 1-ATS Medical gets FDA nod on cardiac-device study | Industries | Healthcare | Reuters
or
ATSI,ATSI ATSI: FDA Approval for Clinical Study of ATS 3f(R) Aortic Bioprosthesis
Seems to be coming down after the initial spike because of short trading.
The stock seems to be below its 5 days Moving Avereage (before the FDA approval). This seems to happen more frequent in Biomed stocks. For instance BDSI. Do you think the short effect will disappear and the price will rise soon?